Search Results 1031-1040 of 18602 for hepatitis

1. Rituximab and hyaluronidase human, recombinant (subcutaneous route) - Mayo Clinic

   Hepatitis B, history of or; Kidney problems or; Lung problems (including lung tumor)—May make these conditions worse. Electrolyte or fluid imbalance or ...

2. A Study Using Momelotinib in Transfusion-Dependent Adults with Primary Myelofibrosis, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis - Mayo Clinic

   Chronic active or acute viral hepatitis A, B, or C infection (testing required for hepatitis B and C), or hepatitis B or C carrier; Use of strong cytochrome ...

3. Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid - Mayo Clinic

   Competing etiology for liver disease (e.g., hepatitis C, active hepatitis B ... hepatitis, primary sclerosing cholangitis, Gilbert's Syndrome).

4. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

   ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Hepatitis infectious disease, Acute liver failure. Show more ...

5. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

   ... hepatitis B (known positive hepatitis B virus [HBV] surface antigen [HBsAg] result), hepatitis C; patients with a past or resolved HBV infection (defined as ...

6. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

   Acute hepatitis B or acute hepatitis C. Patients with chronic hepatitis B or hepatitis C may be enrolled provided their liver function is adequate as per ...

7. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

   In the screening hepatitis B assessment (which consists of testing for hepatitis B surface antigen [HBsAg], hepatitis B core anti-body [HBcAb], and if ...

8. Science Saturday: Vaccine efforts move forward at Mayo Clinic

   A lab member is purifying an adenovirus vector for preclinical testing. They've also examined using this vaccine technology for cytomegalovirus, hepatitis C and ...

9. A Study to Determine the Effectiveness and Safety of Benralizumab for Patients with Severe Nasal Polyposis - Mayo Clinic

   ... hepatitis B or C. NOTE: Patients with history of hepatitis B vaccination without history of hepatitis B are allowed to enroll. History of known ...

10. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

    ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Hepatitis infectious disease, Acute liver failure. Show more ...